Harvard Bioscience Schedules Second Quarter 2024 Earnings Conference Call for August 8, 2024 at 10:00 AM ET

Company Overview - Harvard Bioscience, Inc. is a leading developer, manufacturer, and seller of technologies, products, and services that enable advances in life science applications, including research, pharmaceutical and therapy discovery, bio-production, and preclinical testing for pharmaceutical and therapy development [3] - The company serves a diverse customer base, including renowned academic institutions, government laboratories, and leading pharmaceutical, biotechnology, and contract research organizations [3] - Harvard Bioscience operates in the United States, Europe, and China, utilizing both direct and distribution channels to reach customers globally [3] Upcoming Financial Results - Harvard Bioscience will announce its financial results for the quarter ended June 30, 2024, before the market opens on August 8, 2024 [1] - A conference call to discuss the results will be held at 10:00 a.m. Eastern Time on the same day [1] - Participants interested in joining the call must register to receive dial-in numbers and a unique PIN [1][2] Investor Relations - Financial information presented during the conference call, including the earnings release and a related slide presentation, will be available on the Investor Relations section of Harvard Bioscience's website [2] - The company provides contact information for investor inquiries, including a dedicated team at Three Part Advisors [4]